Post by PharmaShots

CinnaGen receives its first-ever EU marketing authorization as the European Commission approves Zandoriah (Teriparatide) biosimilar for osteoporosis, expanding the company’s presence in highly regulated global markets Subscribe to our weekly newsletter and never miss a beat: https://lnkd.in/gTU62Zbz #cinnagen #ec #approval #zandoriah #biosimilar #forsteo #teriparatide #osteoporosis #parathyroidhormone #regulatory https://lnkd.in/evTPrFqv